Trump's First-Term Policies Lowered Some Insulin Costs, HHS Report Says
A new HHS report found that policies enacted during Trump's first term contributed to lower insulin costs for some patients. The report highlights specific regulatory changes that reduced out-of-pocket expenses. This matters because insulin affordability remains a critical issue for millions of Americans with diabetes.